Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FLEXION THERAPEUTICS, INC.

(FLXN)
SummaryQuotesChartsNewsRatingsCompanyFinancials 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Flexion Therapeutics, Inc.(NasdaqGM:FLXN) dropped from S&P TMI Index

11/19/2021 | 12:00am EST

Flexion Therapeutics, Inc.(NasdaqGM:FLXN) dropped from S&P TMI Index


ę S&P Capital IQ 2021
All news about FLEXION THERAPEUTICS, INC.
2021Pacira BioSciences Logs Higher Exparel, Iovera Sales in November
MT
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
2021Northland Securities Downgrades Flexion Therapeutics to Market Perform From Outperform,..
MT
2021FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Termination of a Ma..
AQ
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P TMI Index
CI
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from NASDAQ Composite Index
CI
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P Global BMI Index
CI
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from NASDAQ Biotechnology Index
CI
2021FLEXION THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
2021Flexion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
More news
Analyst Recommendations on FLEXION THERAPEUTICS, INC.
More recommendations
Financials (USD)
Sales 2020 85,6 M - -
Net income 2020 -114 M - -
Net Debt 2020 56,0 M - -
P/E ratio 2020 -4,57x
Yield 2020 -
Capitalization 459 M 459 M -
EV / Sales 2019 11,7x
EV / Sales 2020 7,31x
Nbr of Employees -
Free-Float 95,6%
Chart FLEXION THERAPEUTICS, INC.
Duration : Period :
Flexion Therapeutics, Inc. Technical Analysis Chart | FLXN | US33938J1060 | MarketScreener
Income Statement Evolution
Managers and Directors
Carolyn Beaty Scimemi Chief Compliance Officer & Head-Legal Affairs
Scott A. Young VP-Corporate Communications & Investor Relations
Sector and Competitors